Skip to main content
. 2009 Nov 12;32(1):1–18. doi: 10.1159/000235758

Table 3.

Binding of non-selective CB receptor ligand, [3H]CP55540, in pluteus, spleen or brain, ± CB2 or CB1 receptor antagonist

Tissue Total [3H] CP55540 bound fmol/μg (mean ± SEM) + CB2 receptor antagonist, SR144 Total [3H]CP55540 bound + CB1 receptor antagonist, SR141
Pluteus 0.009 ± 0.002 0.002 ± 0.002 0.007 ± 0.002 0.007 ± 0.005
Brain 0.099 ± 0.039 0.049 ± 0.022 0.160 ± 0.01 0.048 ± 0.012
Spleen 0.046 ± 0.002 0.006 ± 0.006 ND ND

Experiments were run in duplicate with two replicates for each condition.

p < 0.05 (one-way ANOVA; Newman-Keuls post-hoc test). ND = Not determined.

HHS Vulnerability Disclosure